Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

332
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
332
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

400
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
400
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

289
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
289
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

4.2K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
4.2K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

377
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
377
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

979
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
979

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lead Locally, Impact Nationally: Roles and Responsibilities for Site PI in PHM Research.

Hospital pediatrics·2026
Same author

Strengthening Advocacy Through Clinician Partnerships with Government Relations and Other Policy Experts: Recent Advances.

Academic pediatrics·2026
Same author

Impact of the 2025 Accreditation Council for Graduate Medical Education Pediatric Residency Changes on the Pediatric Hospital Medicine Workforce.

Hospital pediatrics·2026
Same author

When a Meal Train Isn't an Option.

Hospital pediatrics·2026
Same author

Underprioritized and Underfunded: Payment Policy Challenges Facing Hospitals Caring for Children.

Pediatrics·2025
Same author

Family-Reported Posthospitalization Outcomes for Children With Complex Chronic Disease.

Pediatrics·2025

Related Experiment Video

Updated: Feb 25, 2026

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
04:20

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

639

Health Care Expenditures and Utilization for Children With Noncomplex Chronic Disease.

Erik R Hoefgen1, Annie L Andrews2, Troy Richardson3

  • 1Division of Hospital Medicine, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, Ohio; erik.hoefgen@cchmc.org.

Pediatrics
|August 3, 2017
PubMed
Summary

Children with noncomplex chronic diseases (NC-CDs) represent a significant portion of pediatric Medicaid spending, costing $2801 per member per year. Their healthcare utilization and costs are substantially higher than those without chronic conditions.

More Related Videos

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

604
Development and Implementation of a Multi-Disciplinary Technology Enhanced Care Pathway for Youth and Adults with Concussion
08:13

Development and Implementation of a Multi-Disciplinary Technology Enhanced Care Pathway for Youth and Adults with Concussion

Published on: January 20, 2019

7.2K

Related Experiment Videos

Last Updated: Feb 25, 2026

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
04:20

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

639
Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

604
Development and Implementation of a Multi-Disciplinary Technology Enhanced Care Pathway for Youth and Adults with Concussion
08:13

Development and Implementation of a Multi-Disciplinary Technology Enhanced Care Pathway for Youth and Adults with Concussion

Published on: January 20, 2019

7.2K

Area of Science:

  • Pediatric Health Economics
  • Healthcare Management
  • Public Health Policy

Background:

  • Pediatric healthcare expenditures vary significantly based on illness complexity and chronicity.
  • Understanding costs associated with noncomplex chronic diseases (NC-CDs) in children is crucial for resource allocation.

Purpose of the Study:

  • To determine the healthcare expenditures and utilization patterns for children with NC-CDs within the Medicaid population.
  • To compare these expenditures and utilization against children without chronic diseases (WO-CDs) and those with complex chronic diseases (C-CDs).

Main Methods:

  • Retrospective, cross-sectional analysis of Medicaid enrollees (ages 0-18) from 2012-2013.
  • Utilized Truven MarketScan Medicaid Database administrative claims.
  • Categorized patients into WO-CDs (CRG 1-2), NC-CDs (CRG 3-5), and C-CDs (CRG 6-9) using 3M Clinical Risk Groups (CRGs).

Main Results:

  • Children with NC-CDs constituted 36% of the pediatric population studied.
  • NC-CDs accounted for 33% of annual spending ($2801 PMPY), significantly more than WO-CDs ($1151 PMPY).
  • Median outpatient visits over 2 years were 15 for NC-CDs, compared to 8 for WO-CDs and 34 for C-CDs.

Conclusions:

  • Children with NC-CDs incur substantially higher per-member-per-year and aggregate annual expenditures than children without chronic diseases.
  • The significant societal cost of NC-CDs in children, estimated at ~$34.9 billion annually in national Medicaid spending, warrants attention.
  • Targeted interventions for NC-CDs could optimize pediatric healthcare resource allocation and reduce overall costs.